These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 28446712)
1. Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy. Ming J; Sun B; Li Z; Lin L; Meng X; Han B; Wang R; Wu P; Li J; Cai J; Jiang C Aging (Albany NY); 2017 Apr; 9(4):1233-1247. PubMed ID: 28446712 [TBL] [Abstract][Full Text] [Related]
2. GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment. Li J; Cai J; Zhao S; Yao K; Sun Y; Li Y; Chen L; Li R; Zhai X; Zhang J; Jiang C J Exp Clin Cancer Res; 2016 Nov; 35(1):184. PubMed ID: 27894350 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy. Ulasov IV; Nandi S; Dey M; Sonabend AM; Lesniak MS Mol Med; 2011; 17(1-2):103-12. PubMed ID: 20957337 [TBL] [Abstract][Full Text] [Related]
5. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
6. Regulation of epithelial-mesenchymal transition via sonic hedgehog/glioma-associated oncogene homolog 1 signaling pathway in peritoneal mesothelial cells. Xu Y; Wang J; Ding H Cell Biol Int; 2020 Aug; 44(8):1691-1700. PubMed ID: 32298032 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation. Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008 [TBL] [Abstract][Full Text] [Related]
8. Carnosol inhibits Hedgehog signaling pathway in both LNCaP and DU145 prostate cancer cell lines. Gao H; Song Q; Yang J; Yu S; Zhao J; Yu G Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):104-108. PubMed ID: 28886322 [TBL] [Abstract][Full Text] [Related]
9. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction. Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385 [TBL] [Abstract][Full Text] [Related]
10. N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide. Tang JB; Svilar D; Trivedi RN; Wang XH; Goellner EM; Moore B; Hamilton RL; Banze LA; Brown AR; Sobol RW Neuro Oncol; 2011 May; 13(5):471-86. PubMed ID: 21377995 [TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses malignant glioma cells growth and induces apoptosis by inhibition of SHH/GLI1 signaling pathway in vitro and vivo. Du WZ; Feng Y; Wang XF; Piao XY; Cui YQ; Chen LC; Lei XH; Sun X; Liu X; Wang HB; Li XF; Yang DB; Sun Y; Zhao ZF; Jiang T; Li YL; Jiang CL CNS Neurosci Ther; 2013 Dec; 19(12):926-36. PubMed ID: 24165291 [TBL] [Abstract][Full Text] [Related]
12. Differential role of Pax6 and its interaction with Shh-Gli1-IDH2 axis in regulation of glioma growth and chemoresistance. Farheen S; Ahmed SP; Mariyath P M M; Kausar T; Hoda MF; Arif SH; Nayeem SM; Ali A; Chosdol K; Shahi MH J Biochem Mol Toxicol; 2023 Feb; 37(2):e23241. PubMed ID: 36205257 [TBL] [Abstract][Full Text] [Related]
13. Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling. Lan T; Zhao Z; Qu Y; Zhang M; Wang H; Zhang Z; Zhou W; Fan X; Yu C; Zhan Q; Song Y Oncotarget; 2016 Aug; 7(34):55555-55571. PubMed ID: 27487130 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment. Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014 [TBL] [Abstract][Full Text] [Related]
15. The sonic hedgehog signaling pathway stimulates anaplastic thyroid cancer cell motility and invasiveness by activating Akt and c-Met. Williamson AJ; Doscas ME; Ye J; Heiden KB; Xing M; Li Y; Prinz RA; Xu X Oncotarget; 2016 Mar; 7(9):10472-85. PubMed ID: 26859575 [TBL] [Abstract][Full Text] [Related]
16. Essential role of Gli proteins in glioblastoma multiforme. Santoni M; Burattini L; Nabissi M; Morelli MB; Berardi R; Santoni G; Cascinu S Curr Protein Pept Sci; 2013 Mar; 14(2):133-40. PubMed ID: 23544423 [TBL] [Abstract][Full Text] [Related]
17. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma. Kim SM; Woo JS; Jeong CH; Ryu CH; Jang JD; Jeun SS Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439 [TBL] [Abstract][Full Text] [Related]
18. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair. Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141 [TBL] [Abstract][Full Text] [Related]
19. KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation. Yu G; Wu F; Wang E Cell Physiol Biochem; 2016; 38(4):1596-604. PubMed ID: 27081861 [TBL] [Abstract][Full Text] [Related]
20. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways. Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]